Table 2 Amplicons identified using array CGHa

From: Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy

Cytoband

Start

End

Target gene

No. of patients

3q27.1

185 763 900

185 763 959

EPHB3

1

5q33.1

149 481 646

149 514 673

PDGFRB

1

7p11.2

54 746 103

55 363 004

EGFR

1

8q24.13–24.21

126 357 675

128 822 455

MYC

2

9p13.3

33 745 689

33 961 753

PRSS3, UBE2R2, UBAP2

1

10q26

123 264 724

13 123 458 467

FGFR2

2

17q12

35 046 052

35 282 145

ERBB2

2

17q21.2

36 110 139

36 230 022

KRT24, KRT25A, KRT25C, KRT25D, KRT10

2

17q21.2

36 569 493

36 888 515

KRTAP4-4, KRTAP4-10, KRTAP9-9, KRTAP9-4, KRTAP17-1, KRTHA3A, KRTHA3B, KRTHA4, KRTHA1, KRTHA7, KRTHA8, KRTHA2, KRTHA5

1

  1. Abbreviation: CGH, comparative genomic hybridization.
  2. aDefined by aberrations with average tumor/normal log2 ratio >2.0 for ⩾5 consecutive probes.
Back to article page